Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system by Wensheng Liu, Wensheng Liu, Feifei Gao, Feifei Gao, Xue Song, Hao Chen, Hao Chen, Youjun She, Youjun She, Jiyong Liu, Jiyong Liu, Qiong Du, Qiong Du

Get full text